These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31783015)

  • 1. In-Hospital Mortality-Associated Factors in Patients With Thrombotic Antiphospholipid Syndrome Requiring ICU Admission.
    Pineton de Chambrun M; Larcher R; Pène F; Argaud L; Mayaux J; Jamme M; Coudroy R; Mathian A; Gibelin A; Azoulay E; Tandjaoui-Lambiotte Y; Dargent A; Beloncle FM; Raphalen JH; Couteau-Chardon A; de Prost N; Devaquet J; Contou D; Gaugain S; Trouiller P; Grangé S; Ledochowski S; Lemarie J; Faguer S; Degos V; Luyt CE; Combes A; Amoura Z
    Chest; 2020 May; 157(5):1158-1166. PubMed ID: 31783015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission.
    Pineton de Chambrun M; Larcher R; Pène F; Argaud L; Demoule A; Jamme M; Coudroy R; Mathian A; Gibelin A; Azoulay E; Tandjaoui-Lambiotte Y; Dargent A; Beloncle FM; Raphalen JH; Couteau-Chardon A; de Prost N; Devaquet J; Contou D; Gaugain S; Trouiller P; Grangé S; Ledochowski S; Lemarie J; Faguer S; Degos V; Combes A; Luyt CE; Amoura Z;
    J Autoimmun; 2019 Sep; 103():102292. PubMed ID: 31253464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematological features and alternate diagnoses in critically ill thrombotic antiphospholipid syndrome patients.
    Azoulay LD; Frapard T; Larcher R; Pène F; Argaud L; Mayaux J; Jamme M; Coudroy R; Mathian A; Gibelin A; Azoulay E; Tandjaoui-Lambiotte Y; Dargent A; Beloncle FM; Raphalen JH; Bréchot N; de Prost N; Devaquet J; Contou D; Gaugain S; Trouiller P; Grangé S; Ledochowski S; Lemarie J; Faguer S; Degos V; Frere C; Quentric P; Moyon Q; Luyt CE; Combes A; Amoura Z; Pineton de Chambrun M
    Clin Rheumatol; 2024 Sep; 43(9):2889-2898. PubMed ID: 39073513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome.
    Williams FM; Chinn S; Hughes GR; Leach RM
    Ann Rheum Dis; 2002 May; 61(5):414-21. PubMed ID: 11959765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid Patients Admitted in the Intensive Care Unit: What Must The Rheumatologist Know?
    Moyon Q; Mathian A; Papo M; Combes A; Amoura Z; Pineton de Chambrun M
    Curr Rheumatol Rep; 2024 Jul; 26(7):269-277. PubMed ID: 38652403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid syndrome: frequency, main causes and risk factors of mortality.
    Espinosa G; Cervera R
    Nat Rev Rheumatol; 2010 May; 6(5):296-300. PubMed ID: 20386563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
    Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
    Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients.
    Azoulay LD; Pineton de Chambrun M; Larcher R; Pène F; Argaud L; Mayaux J; Jamme M; Coudroy R; Mathian A; Gibelin A; Azoulay E; Tandjaoui-Lambiotte Y; Dargent A; Beloncle F; Raphalen JH; Troger A; de Prost N; Devaquet J; Contou D; Gaugain S; Trouiller P; Grangé S; Ledochowski S; Lemarie J; Faguer S; Degos V; Moyon Q; Luyt CE; Kerneis M; Combes A; Amoura Z
    J Autoimmun; 2022 Dec; 133():102908. PubMed ID: 36126365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center.
    Serrano R; Pons-Estel GJ; Espinosa G; Quintana RM; Reverter JC; Tassies D; Monteagudo J; Cervera R
    Lupus; 2020 Aug; 29(9):1050-1059. PubMed ID: 32536318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
    Cervera R; Serrano R; Pons-Estel GJ; Ceberio-Hualde L; Shoenfeld Y; de Ramón E; Buonaiuto V; Jacobsen S; Zeher MM; Tarr T; Tincani A; Taglietti M; Theodossiades G; Nomikou E; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Fernández-Nebro A; Haro M; Amoura Z; Miyara M; Tektonidou M; Espinosa G; Bertolaccini ML; Khamashta MA;
    Ann Rheum Dis; 2015 Jun; 74(6):1011-8. PubMed ID: 24464962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid syndrome.
    Lim W
    Hematology Am Soc Hematol Educ Program; 2013; 2013():675-80. PubMed ID: 24319251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and long term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: a retrospective study.
    Antón JM; Castro P; Espinosa G; Marcos M; Gandía M; Merchán R; Cervera R; Nicolás JM
    Clin Exp Rheumatol; 2012; 30(3):338-44. PubMed ID: 22338619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients.
    Stammler R; Nguyen Y; Yelnik C; Le Guern V; Lambert M; Paule R; Hachulla E; Mouthon L; Dupré A; Ackermann F; Dufrost V; Wahl D; Godeau B; Leroux G; Benhamou Y; Lazaro E; Daugas E; Bezanahary H; Mekinian A; Piette JC; Morel N; Costedoat-Chalumeau N
    J Thromb Haemost; 2023 May; 21(5):1258-1265. PubMed ID: 36792010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].
    Gu JY; Lu C; Shi H; Yang CD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cessation of oral anticoagulants in antiphospholipid syndrome.
    Comarmond C; Jego P; Veyssier-Belot C; Marie I; Mekinian A; Elmaleh-Sachs A; Leroux G; Saadoun D; Oziol E; Fraisse T; Hyvernat H; Thiercein-Legrand MF; Sarrot-Reynauld F; Ferreira-Maldent N; de Menthon M; Goujard C; Khau D; Nguen Y; Monnier S; Michon A; Castel B; Decaux O; Piette JC; Cacoub P
    Lupus; 2017 Oct; 26(12):1291-1296. PubMed ID: 28355985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catastrophic antiphospholipid syndrome: a case series.
    Shiber S; Yair M
    Isr Med Assoc J; 2013 Sep; 15(9):481-4. PubMed ID: 24340837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features, risk factors, and outcomes of diffuse alveolar hemorrhage in antiphospholipid syndrome: A mixed-method approach combining a multicenter cohort with a systematic literature review.
    Figueroa-Parra G; Meade-Aguilar JA; Langenfeld HE; González-Treviño M; Hocaoglu M; Hanson AC; Prokop LJ; Murad MH; Cartin-Ceba R; Specks U; Majithia V; Crowson CS; Duarte-García A
    Clin Immunol; 2023 Nov; 256():109775. PubMed ID: 37722463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab.
    Berman H; Rodríguez-Pintó I; Cervera R; Morel N; Costedoat-Chalumeau N; Erkan D; Shoenfeld Y; Espinosa G;
    Autoimmun Rev; 2013 Sep; 12(11):1085-90. PubMed ID: 23777822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients.
    Ma J; Song H; Wei M; He Y
    Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up].
    Reshetniak TM; Alekberova ZS; Kotel'nikova GP; Aleksandrova EN; Mach ES; Radenska-Lopovok SG; Kalashnikova LA; Nasonova VA
    Ter Arkh; 2003; 75(5):46-51. PubMed ID: 12847898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.